Artur M. S. Silva
University of Aveiro
976 Papers
4.9K Citations
Artur M. S. Silva is an academic researcher from University of Aveiro. The author has contributed to research in topics: Chemistry & Catalysis. The author has an hindex of 54, co-authored 895 publications. Previous affiliations of Artur M. S. Silva include University of Porto & University of Santiago de Compostela.
Chat about Author
Papers
Flavone—Nitrogen Heterocycle Conjugate Formation by 1,3-Dipolar Cycloadditions.
Regina M. S. Sousa,Diana C. G. A. Pinto,Artur M. S. Silva,Vanda Vaz Serra,Ana Barros,Maria A. F. Faustino,Maria G. P. M. S. Neves,José A. S. Cavaleiro +7 more
TL;DR: The reactions of glycine substrates such as (I or (XVII) and formaldehyde with various dipolarophiles allows the construction of a variety of flavone-nitrogen heterocyclic products.
The Heck Reaction of Protected Hydroxychromones: En Route to Natural Products.
TL;DR: The Heck reaction is applied under phosphine-free conditions to the alkenylation of chromones such as (I) as mentioned in this paper, where the Heck reaction can be applied to any chromone.
2H‐Pyran‐2‐one‐3‐carbothioamide Derivatives: Synthesis and Reaction with Hydrazine Hydrate.
TL;DR: In this article, arylisothiocyanates with 4-hydroxy-6-methylpyran-2-one and 4hydroxycoumarin-3-carboximidamides were synthesized.
Ferrocenylphosphines as New Catalysts for Baylis—Hillman Reactions.
TL;DR: In this paper, a set of readily accessible planar chiral ferrocenyldialkylphosphines have been tested in asymmetric Baylis−Hillman reactions and the best enantioselectivities were obtained using Mandyphos as chiral catalyst.
Recent Advances in Fluorescent Theranostics for Alzheimer’s Disease: A Comprehensive Survey on Design, Synthesis, and Properties
Telmo Francisco,Daniela Malafaia,Lúcia Melo,Artur M. S. Silva,Hélio M. T. Albuquerque +4 more
TL;DR: This review surveys recent advances in small-molecule near-infrared fluorescent theranostics for Alzheimer's disease, detailing design strategies, synthetic approaches, and imaging and therapeutic properties, aiming to provide a milestone in AD theranostics and encourage future clinical applications.